Royalty Pharma plcRPRXNASDAQ
Loading
Gross Profit Growth AcceleratingAccelerating
Percentile Rank50
5Y CAGR-21.5%
Year-over-Year Change
Year-over-year gross profit growth rate
5Y CAGR
-21.5%/yr
Long-term compound
Percentile
P50
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 5.06% |
| 2024 | -3.86% |
| 2023 | 5.24% |
| 2022 | -2.28% |
| 2021 | 7.87% |
| 2020 | 16.98% |
| 2019 | 1.08% |
| 2018 | 12.33% |
| 2017 | -14.89% |
| 2016 | 13.62% |